Journal of Alzheimer s Disease · 2016 · 77 citations · 73 references
Life SciencesBiochemistryMolecular BiologyDementiaProtein BiochemistryProteomicsAlzheimer DiseaseBiomarkers Of NeurodegenerationClinical ProteomicsDementia BiomarkersProteomic BiomarkersQuantitative ProteomicsBiomarkersDifferential Protein Expression AnalysisDisease ProteomicsProtein Analysis In Body FluidsProtein Expression ProfilingProteomic Biomarker ValidationSerum Protein BiomarkersSerum Proteomics
Alzheimer' disease (AD) is the most common form of dementia affecting up to 6% of the population over the age of 65. In order to discover differentially expressed proteins that might serve as potential biomarkers, the serums from AD patients and healthy controls were compared and analyzed using the proteomics approach of isobaric tagging for relative and absolute quantitation (iTRAQ). For the first time, AD biomarkers in serums are investigated in the Han Chinese population using iTRAQ labeled proteomics strategy. Twenty-two differentially expressed proteins were identified and out of which nine proteins were further validated with more sample test. Another three proteins that have been reported in the literature to be potentially associated with AD were also investigated for alteration in expression level. Functions of those proteins were mainly related to the following processes: amyloid-β (Aβ) metabolism, cholesterol transport, complement and coagulation cascades, immune response, inflammation, hemostasis, hyaluronan metabolism, and oxidative stress. These results support current views on the molecular mechanism of AD. For the first time, differential expression of zinc-alpha-2-glycoprotein (AZGP1), fibulin-1 (FBLN1), platelet basic protein (PPBP), thrombospondin-1 (THBS1), S100 calcium-binding protein A8 (S100A8), and S100 calcium-binding protein A9 (S100A9) were detected in the serums of AD patients compared with healthy controls. These proteins might play a role in AD pathophysiology and serve as potential biomarkers for AD diagnosis. Specifically, our results strengthened the crucial role of Aβ metabolism and blood coagulation in AD pathogenesis and proteins related to these two processes may be used as peripheral blood biomarkers for AD.
73
Proteome-based plasma biomarkers for Alzheimer's disease
Abdul Hye, Steven Lynham, Madhav Thambisetty et al. · Brain · 2006 · 474 citations · Full text
Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
James D. Doecke · Archives of Neurology · 2012 · 421 citations · Full text
Medicine, Biochemistry, Neurology +17
Federico Licastro, Steve Pedrini, Ludovica Caputo et al. · Journal of Neuroimmunology · 2000 · 401 citations · Full text
Life Sciences, Immunology, Neurology +14
Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury
Bharatkumar N. Patel, Robert Dunn, Suh Young Jeong et al. · Journal of Neuroscience · 2002 · 372 citations · Full text
Medicine, Neurobiology, Neuroscience +17